Impax Labs Hit With Patent Suit Over Ultram ANDA

Law360, New York (August 12, 2008, 12:00 AM EDT) -- Biovail Laboratories International SRL and its U.S. partner, Ortho-McNeil Inc., have sued California-based Impax Laboratories Inc. over the company's application to make generic Ultram ER, a treatment for chronic pain.

Biovail, which manufactures Ultram, and Ortho-McNeil, which markets the drug in the U.S., filed suit Friday in the U.S. District Court for the District of Delaware over Impax's abbreviated new drug application with the U.S. Food and Drug Administration.

The suit claims Impax infringed U.S. Patent Number 6,254,887, which covers controlled release tramadol and is listed...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.